Skip to Main Content

DexCom, Inc.

DXCM Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership

$DXCM is featured in our Tina Smith strategy.

See All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of DXCM by members of U.S. Congress

Politician Type Traded
Robert Bresnahan House / R Purchase $1,001 - $15,000 Feb. 25, 2025
Kevin Hern House / R Sale $50,001 - $100,000 Dec. 31, 2024
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 12, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Aug. 21, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 28, 2022
Kevin Hern House / R Purchase $100,001 - $250,000 Jul. 01, 2021
Thomas R. Suozzi House / D Sale $15,001 - $50,000 Jun. 03, 2021
Peter Meijer House / R Sale $1,001 - $15,000 Feb. 16, 2021
Josh Gottheimer House / D Sale $1,001 - $15,000 Dec. 24, 2020
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Dec. 22, 2020
Susie Lee House / D Sale $1,001 - $15,000 Oct. 02, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Sep. 16, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Aug. 13, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 May. 11, 2020
Tina Smith Senate / D Sale (Partial) $250,001 - $500,000 Mar. 17, 2020
Thomas R. Suozzi House / D Purchase $1,001 - $15,000 Jan. 10, 2020
Thomas R. Suozzi House / D Purchase $15,001 - $50,000 Jan. 09, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Jul. 16, 2019
Bradley Scott Schneider House / D Sale $100,001 - $250,000 Jun. 20, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Jun. 13, 2019
Bradley Scott Schneider House / D Purchase $100,001 - $250,000 Jun. 20, 2017
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jan. 13, 2017
Thomas MacArthur House / R Sale $1,001 - $15,000 May. 27, 2015
DXCM Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
DXCM Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
DXCM Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by DXCM's directors and management

Government lobbying spending instances

  • $260,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $130,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $170,000 Sep 06, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $160,000 Sep 06, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $56,500 Jan 03, 2024 Issue: Medicare/Medicaid Health Issues
  • $56,500 Oct 19, 2023 Issue: None
  • $67,450 Jul 12, 2023 Issue: Medicare/Medicaid
  • $62,000 Jan 10, 2023 Issue: Health Issues
  • $56,500 Oct 12, 2022 Issue: Economics/Economic Development Medicare/Medicaid
  • $57,000 Jul 12, 2022 Issue: Health Issues
  • $57,000 May 05, 2022 Issue: Medicare/Medicaid Health Issues
  • $57,000 Mar 23, 2022 Issue: Medicare/Medicaid Health Issues
  • $57,000 Oct 05, 2021 Issue: None
  • $57,000 Jul 02, 2021 Issue: None
  • $58,600 Apr 14, 2021 Issue: None
  • $56,274 Jan 08, 2021 Issue: HEALTH ISSUES
  • $57,250 Oct 19, 2020 Issue: MEDICARE/MEDICAID
  • $58,600 Jul 13, 2020 Issue: MEDICARE/MEDICAID
  • $58,632 Apr 13, 2020 Issue: None
  • $57,250 Jan 10, 2020 Issue: None
  • $56,274 Oct 08, 2019 Issue: Health Issues Medicare/Medicaid
  • $52,675 Jul 12, 2019 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 22, 2019 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 22, 2019 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 19, 2018 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues
  • $180,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues
  • $250,000 Apr 19, 2018 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 19, 2018 Issue: Medicare/Medicaid Health Issues
  • $7,651 Jan 16, 2018 Issue: Health Issues Medicare/Medicaid
  • $9,700 Oct 23, 2017 Issue: Medicare/Medicaid
  • $6,750 Jul 21, 2017 Issue: Health Issues
  • $8,375 Jul 21, 2017 Issue: Health Issues
  • $80,000 Jul 18, 2017 Issue: Medicare/Medicaid Health Issues
  • $130,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid
  • $25,650 Jan 23, 2017 Issue: Health Issues
  • $120,000 Jan 23, 2017 Issue: Medicare/Medicaid Health Issues
  • $12,750 Oct 20, 2016 Issue: Health Issues
  • $150,000 Oct 17, 2016 Issue: Medicare/Medicaid Health Issues
  • $130,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues
  • $36,000 Jul 20, 2016 Issue: Health Issues
  • $36,000 Apr 20, 2016 Issue: Health Issues
  • $20,000 Apr 19, 2016 Issue: Health Issues
  • $70,000 Jan 15, 2016 Issue: Health Issues
  • $70,000 Oct 14, 2015 Issue: Health Issues
  • $60,000 Jul 16, 2015 Issue: Health Issues
  • $50,000 Apr 18, 2015 Issue: Health Issues
  • $20,000 Jan 18, 2015 Issue: Health Issues
  • $40,000 Oct 16, 2014 Issue: Health Issues
  • $60,000 Jul 17, 2014 Issue: Health Issues
  • $20,000 Apr 20, 2014 Issue: Health Issues
  • $40,000 Aug 12, 2007 Issue: Health Issues
  • $100,000 Feb 09, 2007 Issue: Health Issues

Estimated quarterly lobbying spending

DXCM Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
DXCM Income Statement
DXCM Balance Sheet
DXCM Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Indicator and analytics for sensor insertion in a continuous analyte monitoring system and related methods Apr. 08, 2025
  • Patent Title: Automatic analyte sensor calibration and error detection Mar. 25, 2025
  • Patent Title: Nfc beacons for bidirectional communication between an electrochemical sensor and a reader device Mar. 18, 2025
  • Patent Title: Sensor interposer employing castellated through-vias Mar. 11, 2025
  • Patent Title: Integrated insulin delivery system with continuous glucose sensor Mar. 11, 2025
  • Patent Title: Analyte data processing, reporting, and visualization Mar. 04, 2025
  • Patent Title: System, method and article for controlling the dispensing of insulin Feb. 25, 2025
  • Patent Title: Sharing continuous glucose data and reports Feb. 25, 2025
  • Patent Title: Integrated delivery device for continuous glucose sensor Feb. 18, 2025
  • Patent Title: Retrospective retrofitting method to generate a continuous glucose concentration profile by exploiting continuous glucose monitoring sensor data and blood glucose measurements Feb. 18, 2025
  • Patent Title: Analyte sensors and methods of manufacturing same Feb. 11, 2025
  • Patent Title: Glucose prediction using machine learning and time series glucose measurements Jan. 21, 2025
  • Patent Title: Systems and method for activating analyte sensor electronics Jan. 21, 2025
  • Patent Title: Systems and methods for distributing continuous glucose data Jan. 14, 2025
  • Patent Title: Medical device inserter Jan. 14, 2025
  • Patent Title: Continuous glucose monitor communication with multiple display devices Jan. 07, 2025
  • Patent Title: Method of packaging analyte sensors Jan. 07, 2025
  • Patent Title: Receivers for analyzing and displaying sensor data Dec. 31, 2024
  • Patent Title: System and method for providing personalized guidance to diabetes patients Dec. 24, 2024
  • Patent Title: Systems and methods for processing sensor data Dec. 10, 2024
  • Patent Title: Dynamic patient health information sharing Dec. 03, 2024
  • Patent Title: Combination medical device receiver and display Dec. 03, 2024
  • Patent Title: Adaptive interface for continuous monitoring devices Nov. 26, 2024
  • Patent Title: Transcutaneous analyte sensor applicator Nov. 26, 2024
  • Patent Title: Pre-connected analyte sensors Nov. 19, 2024
  • Patent Title: Evaluation and visualization of glycemic dysfunction Nov. 19, 2024
  • Patent Title: Preconnected analyte sensors Nov. 19, 2024
  • Patent Title: Continuous analyte monitoring system power conservation Nov. 19, 2024
  • Patent Title: System and method for mode switching Nov. 19, 2024
  • Patent Title: System and method for mode switching Nov. 19, 2024
  • Patent Title: Continuous analyte monitor data recording device operable in a blinded mode Nov. 19, 2024
  • Patent Title: Diabetes management partner interface for wireless communication of analyte data Nov. 12, 2024
  • Patent Title: Time averaged basal rate optimizer Nov. 12, 2024
  • Patent Title: Systems and methods for distributing continuous glucose data Nov. 05, 2024
  • Patent Title: Preconnected analyte sensors Oct. 29, 2024
  • Patent Title: Systems and methods for enhanced wireless communications between analyte sensor systems and display devices Oct. 22, 2024
  • Patent Title: Systems and methods for processing and transmitting sensor data Oct. 22, 2024
  • Patent Title: Integrated delivery device for continuous glucose sensor Oct. 15, 2024
  • Patent Title: Analyte sensor with impedance determination Oct. 15, 2024
  • Patent Title: Display screen or portion thereof with a graphical user interface Oct. 08, 2024
  • Patent Title: Integrated medicament delivery device for use with continuous analyte sensor Oct. 01, 2024
  • Patent Title: Sensors for continuous analyte monitoring Sep. 17, 2024
  • Patent Title: System and method for activating an analyte monitoring system Sep. 10, 2024
  • Patent Title: Systems and methods for processing and transmitting sensor data Sep. 03, 2024
  • Patent Title: Dynamic report building Sep. 03, 2024
  • Patent Title: Wearable apparatus for continuous blood glucose monitoring Aug. 27, 2024
  • Patent Title: Systems and methods for a continuous monitoring of analyte values Aug. 27, 2024
  • Patent Title: Methods for providing an alert or an alarm to a user of a mobile communications device Aug. 20, 2024
  • Patent Title: Medical device electronic module Aug. 13, 2024
  • Patent Title: Base for medical device electronic module Aug. 13, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
DXCM News

Recent insights relating to DXCM

CNBC Recommendations

Recent picks made for DXCM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DXCM

DXCM Analyst Ratings

DXCM Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
DXCM Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $DXCM stock a Buy, Sell, or Hold?

  • What is the price target for $DXCM stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

DXCM Top Shareholders
Shareholder
Shares Held
DXCM Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $DXCM stock?

  • Who owns the most shares of $DXCM stock?

  • What funds own $DXCM stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

DXCM Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view DXCM Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top